Clinical Trials Browser

Phase 2 × Thyroid Neoplasms × camrelizumab × Clear all

NCT04612894 2020-11-03

Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer

Phase 2 Unknown

Thyroid Neoplasms